Yu Q,
	Stamenkovic I
Molecular Pathology Unit,
	Massachusetts General Hospital,
	and Department of Pathology,
	Harvard Medical School,
Boston,
	Massachusetts 02129 USA.
We have uncovered a novel 
	functional relationship between the hyaluronan receptor CD44,
	the matrix metalloproteinase-9 (MMP-9) and the multifunctional cytokine TGF-beta 
	in the control of tumor-associated tissue remodeling.
CD44 provides a cell surface docking receptor for proteolytically active MMP-9 and we show here that localization of MMP-9 to cell surface is required for its ability to promote tumor invasion and angiogenesis.
Our observations also indicate 
	that MMP-9,
	as well as MMP-2,
	proteolytically cleaves latent TGF-beta,
	providing a novel and potentially important mechanism for TGF-beta activation.
In addition,
	we show that MMP-9 localization to the surface of normal keratinocytes is 
	CD44 dependent and can activate latent TGF-beta.
These observations suggest 
	that coordinated CD44,
	MMP-9,
	and TGF-beta function may provide a physiological mechanism of tissue remodeling 
	that can be adopted by malignant cells to promote tumor growth and invasion.
MeSH Terms:
Animal 
	Antigens,
	CD44/physiology 
	Cell Membrane/enzymology 
	Culture Media,
	Conditioned/pharmacology 
	Endothelium,
	Vascular/pathology 
	Endothelium,
	Vascular/enzymology 
	Gelatinase B/metabolism* 
	Hydrolysis 
	Keratinocytes/metabolism 
	Keratinocytes/enzymology 
	Male 
	Mammary Neoplasms,
	Experimental/pathology 
	Mammary Neoplasms,
	Experimental/enzymology 
	Mammary Neoplasms,
	Experimental/blood supply* 
	Mice 
	Mice,
	Inbred A 
	Mice,
	Mutant Strains 
	Neoplasm Invasiveness 
	Neovascularization,
	Pathologic/pathology 
	Neovascularization,
	Pathologic/metabolism 
	Neovascularization,
	Pathologic/enzymology* 
	Peptide Hydrolases/metabolism* 
	Protein Isoforms/metabolism 
	Support,
	U.S.Gov't,P.H.S.
	Transforming Growth Factor beta/metabolism* 
	Tumor Cells,
	Cultured 
Substances:
Transforming Growth Factor 
	beta 
	Protein Isoforms 
	Culture Media,
	Conditioned 
	Antigens,
	CD44 
	Gelatinase B 
	Peptide Hydrolases 
Grant support:
CA09216/CA/NCI 
	GM48614/GM/NIGMS 
	CA55375/CA/NCI 
PMID: 10652271,
	UI: 20119177